Company Quick10K Filing
GrowGeneration
10-Q 2020-06-30 Filed 2020-08-13
S-1 2020-06-10 Public Filing
10-Q 2020-03-31 Filed 2020-05-14
10-K 2019-12-31 Filed 2020-03-27
10-Q 2019-09-30 Filed 2019-11-12
10-Q 2019-06-30 Filed 2019-08-08
10-Q 2019-03-31 Filed 2019-05-07
10-K 2018-12-31 Filed 2019-04-01
10-Q 2018-09-30 Filed 2018-11-09
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-15
10-K 2017-12-31 Filed 2018-03-27
10-Q 2017-09-30 Filed 2017-11-08
10-Q 2017-06-30 Filed 2017-08-02
10-Q 2017-03-31 Filed 2017-05-15
10-K 2016-12-31 Filed 2017-03-31
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-19
8-K 2020-08-25 Other Events, Exhibits
8-K 2020-08-21 Regulation FD, Other Events, Exhibits
8-K 2020-08-17 Regulation FD
8-K 2020-08-13 Regulation FD, Exhibits
8-K 2020-06-30 Regulation FD, Exhibits
8-K 2020-06-29 Enter Agreement, Exhibits
8-K 2020-06-17
8-K 2020-06-11
8-K 2020-06-10
8-K 2020-05-14
8-K 2020-05-11
8-K 2020-04-22
8-K 2020-03-27
8-K 2020-03-27
8-K 2020-03-11
8-K 2020-02-26
8-K 2020-01-13
8-K 2019-12-18
8-K 2019-12-02
8-K 2019-11-11
8-K 2019-11-04
8-K 2019-09-05
8-K 2019-09-03
8-K 2019-08-08
8-K 2019-07-10
8-K 2019-06-26
8-K 2019-06-21
8-K 2019-05-16
8-K 2019-05-13
8-K 2019-05-03
8-K 2019-02-07
8-K 2019-02-04
8-K 2019-01-21
8-K 2018-12-11
8-K 2018-10-23
8-K 2018-10-16
8-K 2018-09-14
8-K 2018-09-11
8-K 2018-08-28
8-K 2018-08-14
8-K 2018-07-13
8-K 2018-05-16
8-K 2018-05-09
8-K 2018-04-20
8-K 2018-04-12
8-K 2018-04-09
8-K 2018-03-12
8-K 2018-01-30
8-K 2018-01-23
8-K 2018-01-16
8-K 2018-01-08

GrowGeneration Financials

GRWG Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
HOOKIPA Pharma (HOOK) 197,170 0% -2.3 -22% 152,037 26,280 8,324 0 -32,793 -32,034 73,160
Corvus Gold (CORVF) 170,478 -15.3 -106% 10,214 765 0 0 -10,858 -10,858 166,332
Union Bridge Holdings (UGHL) 188,095 26% -422.5 -815% 55 977 65 17 -445 -445 188,075
IDEAYA Biosciences (IDYA) 186,410 -3.7 -18% 122,331 11,925 0 0 -21,625 -21,025 77,010
GrowGeneration (GRWG) 182,705 29% 57.2 3% 68,417 15,626 54,349 16,008 2,341 2,923 167,194
Technovative Group (TEHG) 182,172 57% -105.6 -33% 5,191 3,101 765 437 -1,719 -1,719 181,597
Exagen (XGN) 182,113 54% -60.9 -3% 92,744 34,094 10,439 5,656 -3,141 -2,132 129,862
Soliton (SOLY) 179,964 -14.9 -130% 9,927 2,745 0 0 -12,896 -11,529 171,255
Acro Biomedical (ACBM) 177,190 10% -1,443.4 -13% 1,081 133 3,760 388 -142 -123 177,189
Energy & Technology (ENGT) 177,150 32% -1,446.0 -4% 3,954 9,029 3,101 984 -143 -122 177,039
Kraig Biocraft Laboratories (KBLB) 176,366 -99.2 -224% 899 5,504 0 0 -2,009 -1,775 176,083
American BriVision (ABVC) 175,304 97% -71.6 -38% 7,405 6,675 602 584 -2,817 -2,434 174,252
Vaneck Merk Gold Trust (OUNZ) 175,193 8.4 12% 174,523 0 0 0 20,914 20,914 175,193
Invesco DB Gold Fund (DGL) 174,116 9.8 10% 174,089 3,964 0 0 17,743 17,748 174,116
Fulcrum Therapeutics (FULC) 173,470 -2.4 -26% 115,956 13,828 0 0 -29,711 -29,711 70,781
MariMed (MRMD) 172,389 39% 23.2 -2% 137,056 54,263 40,412 15,889 -2,498 9,162 212,127
Fortem Resources (FTMR) 191,211 -119.9 -1% 143,155 18,644 0 0 -1,741 -1,603 192,221
Cure Pharmaceutical (CURR) 171,305 94% -10.1 -60% 34,029 20,673 284 266 -20,482 -16,320 165,597
FC Global Realty (FCRE) 170,563 86% -62.4 -2% 134,314 52,885 44 38 -2,748 -2,732 170,584
Applied Therapeutics (APLT) 170,485 -5.6 -75% 37,264 6,517 0 0 -27,880 -27,880 157,420

Balance Sheet ($'000)2016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash4515116071,3242,1551,9051,2158,76317,43314,33114,6406,56117,85915,983
Accounts Receivable1483653915085426846547459541,0098621,0781,4202,170
Inventory2,1502,3882,5743,5174,4365,0244,5856,7138,0899,4768,86915,06515,12919,384
PP&E4885326236531,0671,2721,4831,5661,7612,2242,3952,9753,7044,231
Assets3,4744,0304,4436,5999,2369,9999,25421,03832,05536,21035,89343,70659,55368,417
Accounts Payable4455695368141,4761,3191,0681,4731,7551,3411,8193,0292,8664,958
Long-Term Debt767065591641441246356101,049812713584472
Liabilities7008718851,1871,8741,7501,6767,1947,4175,2865,83412,12012,66315,626
Stockholders' Equity2,7743,1603,5585,4127,3638,2497,57913,84424,63730,92430,05931,58646,89152,790
Income Statement ($'000)2016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue1,9072,1692,3632,5844,1114,0283,6414,3817,1528,40613,08719,48321,778
Cost of Revenue1,3371,5601,8291,9032,9602,9123,3193,1915,4236,2499,40113,66315,277
Gross Profit5706095346811,1511,1163231,1901,7292,1573,6875,8206,502
R&D
SG&A221665526225238378364399375493549804
Tax000000
Net Income-14411-220-283-340-461-1,458-953-930-7852291,0621,050
Cash Flow ($'000)2016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-439-293-435-978-593-1,785-1,7361,647-2,4621,601-1,419
Cash Investing-67-44-91-380-279-661-421-5,169-5,520-3,277-1,381
Cash Financing3073976222,0751,7039,99310,828420-9812,974924